GNMK
GenMark Diagnostics, Inc.
Set alert
— — —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 1.77B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 133.56
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 3, 2021
- 50-d avg
- 23.99
- 200-d avg
- 16.94
- 1y target
- 22.52
Key statistics
- Market cap
- 1.77B
- Trailing P/E
- 0.00
- Forward P/E
- 133.56
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 23.99
- 200-day average
- 16.94
Analyst view
Consensus: hold
Hold
Price target (mean) 22.52
- Target (low)
- 21.00
- Target (mean)
- 22.52
- Target (high)
- 24.05
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy4
- Buy3
- Hold1
- Sell0
- Strong sell0
Next earnings
May 3, 2021
Expected May 3, 2021. Consensus EPS estimate 0.00.
Financials — quick view
GNMK Revenue — quarterly 50.08M
GNMK Net income — quarterly -3.72M
GNMK EPS — quarterly -0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 3, 2021 | Mar 1, 2021 | -0.05 | — | — | — |
| Feb 25, 2021 | Dec 1, 2020 | -0.01 | — | — | — |
| Oct 28, 2020 | Sep 1, 2020 | -0.06 | — | — | — |
| Aug 4, 2020 | Jun 1, 2020 | -0.10 | — | — | — |
| May 4, 2020 | Mar 1, 2020 | -0.16 | — | — | — |
| Mar 2, 2020 | Dec 1, 2019 | -0.16 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 17, 2021 | BTIG | down | Buy | Neutral |
| Mar 17, 2021 | Cowen & Co. | down | Outperform | Market Perform |
| Mar 16, 2021 | Canaccord Genuity | down | Buy | Hold |
| Mar 15, 2021 | Needham | down | Buy | Hold |
| Feb 16, 2021 | Canaccord Genuity | main | — | Buy |
| Aug 5, 2020 | Needham | main | — | Buy |
News
Your note
Sign in to keep a note on GNMK — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FAULKNER DARYL J | Director | Stock Award(Grant) | Feb 17, 2021 | 133,871 |
| FOX JAMES CHARLES | Director | Stock Award(Grant) | Feb 17, 2021 | 263,102 |
| GLEESON MICHAEL W | Officer | Conversion of Exercise of derivative security | Apr 13, 2021 | 450,479 |
| HARKINS MICHAEL JOHN | Officer | Sale | Feb 25, 2021 | 143,611 |
| JENSEN TYLER D | Officer | Sale | Mar 17, 2021 | 211,888 |
| KAGNOFF MICHAEL S | Director | Stock Award(Grant) | Feb 17, 2021 | 137,319 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.72% | 10,758,659 | 157.08M | Dec 30, 2020 |
| Wasatch Advisors Inc | 9.13% | 6,672,180 | 97.41M | Dec 30, 2020 |
| Blackrock Inc. | 7.69% | 5,623,577 | 82.10M | Dec 30, 2020 |
| Redmile Group, LLC | 6.21% | 4,537,400 | 66.25M | Dec 30, 2020 |
| Vanguard Group, Inc. (The) | 6.15% | 4,497,904 | 65.67M | Dec 30, 2020 |
| Consonance Capital Management LP | 6.13% | 4,480,163 | 65.41M | Dec 30, 2020 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Select Portfolios - Medical Technology & Devices Port | 4.16% | 3,042,775 | 59.49M | Feb 27, 2021 |
| Delaware Group Equity Fds V-Small Cap Core Fund | 3.15% | 2,304,492 | 30.81M | Nov 29, 2020 |
| Wasatch Ultra Growth Fund | 2.84% | 2,078,857 | 30.35M | Dec 30, 2020 |
| Fidelity Select Portfolios - Health Care | 2.74% | 2,000,000 | 39.10M | Feb 27, 2021 |
| Vanguard Total Stock Market Index Fund | 2.57% | 1,875,383 | 27.38M | Dec 30, 2020 |
| Wasatch Microcap Fund | 2.51% | 1,833,317 | 26.77M | Dec 30, 2020 |